# Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions

> **NCT07423663** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Suez Canal University** · enrollment: 63 (actual)

## Conditions studied

- Asymptomatic Apical Periodontitis

## Interventions

- **DRUG:** Calcium Hydroxide Intracanal medication
- **DRUG:** Calcium silicate based intracanal medication
- **DRUG:** Pectin

## Key facts

- **NCT ID:** NCT07423663
- **Lead sponsor:** Suez Canal University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-03-10
- **Final completion:** 2026-04-01
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07423663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07423663, "Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07423663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*